Weight Loss and Treatment Patterns in a Real-World Population of Adults Receiving Saxenda® for Weight Management in Routine Clinical Practice in Switzerland

Clinical Studies - Mar 25, 2022 - Jun 30, 2022

Completed

Project leader: Aczel Stefan
Members: Räss Andrea

Obesity and type 2 diabetes mellitus (T2DM) are reaching epidemic proportions in the developed world. In morbidly obese patients only surgical treatment (bariatric operations) leads to a sustained weight loss and relief of co-morbidities in the major...

Clinical Studies - Mar 1, 2020 - Feb 28, 2027

Ongoing

Project leader: Peterli Ralph, Folie Patrick
Members: Aczel Stefan, Falconnier Claudine, Greifnieder Dietlind, Schmid Mathias, Lisarelli Loriana, Oettli Seraina, Seiler Edith, Bilz Stefan, Sigrist Sarah

Effect and safety of semaglutide 2.4 mg once-weekly in subjects with overweight or obesity who have reached target dose during run-in period

Clinical Studies - Jun 5, 2018 - May 31, 2020

Completed

Project leader: Bilz Stefan
Members: Sigrist Sarah, Aczel Stefan, Räss Andrea

Eine 26-wöchige, randomisierte, offene, zweiarmige, pragmatische Parallelgruppenstudie unter realen Bedingungen zur Beurteilung des klinischen und gesundheitsrelevanten Nutzens des Wechsels zu Toujeo® im Vergleich zum als Therapiestandard geltenden I...

Clinical Studies - Sep 1, 2016 - Mar 14, 2018

Completed

Project leader: Aczel Stefan
Members: Räss Andrea

Diese Studie dient der Erforschung des klinischen Vorteils eines Therapieausbaus mit Insulin Glargin U300 (Toujeo®), einem neuen Basalinsulin, bei Patienten, deren Diabetes mellitus Typ 2 unter Therapie mit oralen Antidiabetika ungenügend kontrollier...

Clinical Studies - Jan 1, 2016 - Jan 1, 2020

Completed

Project leader: Aczel Stefan
Members: Bilz Stefan